MOKARI ATABAK (Chief Financial Officer) sold 71.3% of their position (40K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $3.51M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+15.83K
Price / share
$19.26
Trade value
$304.94K
% of position
Common Stock
Shares
+24.17K
Price / share
$23.06
Trade value
$557.29K
% of position
Common Stock
Shares
−7.92K
Price / share
$86.78
Trade value
$687.18K
% of position
Common Stock
Shares
−28.46K
Price / share
$87.89
Trade value
$2.50M
% of position
Common Stock
Shares
−3.52K
Price / share
$88.30
Trade value
$310.82K
% of position
Common Stock
Shares
−101.00
Price / share
$89.43
Trade value
$9.03K
% of position
Net shares
+0.00
Net value
-$2.65M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/15/2026 | M · Option Exercise | +15.83K | $19.26 | $304.94K | 98.2% | 16.13K | 31.96K |
| Common Stock Direct | 7/15/2026 | M · Option Exercise | +24.17K | $23.06 | $557.29K | 75.6% | 31.96K | 56.13K |
| Common Stock Direct | 7/15/2026 | S · Sale | −7.92K | $86.78 | $687.18K | 14.1% | 56.13K | 48.21K |
| Common Stock Direct | 7/15/2026 | S · Sale | −28.46K | $87.89 | $2.50M | 59.0% | 48.21K | 19.75K |
| Common Stock Direct | 7/15/2026 | S · Sale | −3.52K | $88.30 | $310.82K | 17.8% | 19.75K | 16.23K |
| Common Stock Direct | 7/15/2026 | S · Sale | −101.00 | $89.43 | $9.03K | 0.6% | 16.23K | 16.13K |
| Total | +0.00 | -$2.65M | ||||||
Stock option (right to buy)
Common Stock
15.83K shares
Shares
−15.83K
Strike price
19.26
Held after
4.17K
Exercisable
—
Stock option (right to buy)
Common Stock
24.17K shares
Shares
−24.17K
Strike price
23.06
Held after
175.83K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock15.83K shares | 7/15/2026 | M · Option Exercise | −15.83K | 19.26 | — | 4.17K |
| Stock option (right to buy) Direct | Common Stock24.17K shares | 7/15/2026 | M · Option Exercise | −24.17K | 23.06 | — | 175.83K |